Table 1 Patient and infection characteristics
Characteristic | N (%) |
|---|---|
Patients included | 373 (100) |
Sex | |
Female | 148 (39.7) |
Male | 225 (60.3) |
Acquisition | |
Community-acquired | 108 (29.0) |
Healthcare-associated | 156 (41.8) |
Hospital-acquired | 109 (29.2) |
Age category | |
<60 | 81 (21.7) |
60-69 | 58 (15.6) |
70-79 | 109 (29.2) |
≥80 | 125 (33.5) |
Comorbid conditions | |
No underlying illness | 20 (5.4) |
Malignancy | 96 (25.7) |
Renal failure | 45 (12.1) |
Diabetes mellitus | 72 (19.3) |
Hypertension | 114 (30.6) |
Cardiovascular disease | 154 (41.3) |
Heart failure | 40 (10.7) |
Chronic pulmonary disease | 62 (16.6) |
Rheumatic disease | 39 (10.5) |
Charlson Comorbidity Index (CCI) | |
0 | 85 (22.8) |
1-2 | 160 (42.9) |
≥3 | 128 (34.3) |
Focus of infection | |
Unknown | 94 (25.2) |
Respiratory focus | 37 (9.9) |
Urinary tract | 33 (8.8) |
Skin/soft tissue | 73 (19.6) |
Abscess | 27 (7.2) |
IV catheter | 28 (7.5) |
Endocarditis | 18 (4.8) |
Osteomyelitis/Septic arthritis | 44 (11.8) |
Other* | 19 (5.1) |
Microbiological characteristics | |
Polymicrobial infection | 25 (6.7) |
Methicillin-resistant isolates | 3 (0.8) |
Penicillin-sensitive isolates§ | 93 (26.7) |
Dicloxacillin-sensitive isolates§ | 346 (99.4) |
Gentamicin-sensitive isolates§$ | 323 (98.5) |
Gentamicin intermediate or resistant§$ | 5 (1.5) |
Time period | |
1996-2003 | 144 (38.6) |
2004-2011 | 229 (61.4) |